Introduction
Cocaine is a stimulant that affects the cardiovascular system and has been associated with cardiovascular disease risk factors, morbidity, and mortality.( n1) Acutely, cocaine increases heart rate and blood pressure in a dosedependent fashion, ( n2-n6) reduces coronary caliber and sinus flow and increases coronary resistance, ( n5) and can induce arrhythmias and other electrocardiographic changes. ( n5, n7-n10) These efffects are enhanced with the concomitant use of alcohol or marijuana.( n11, n12) Although plasma concentrations from similar quantities of cocaine may differ by route of administration, the cardiovascular effects are similar at comparable plasma concentrations regardless of the route of administration. ( n3, n12) Crosssectionally, cocaine use has also been associated with cardiovascular pathology such as myocardial infarction and sudden death, ( n5, n7-n10, n13-n18) and cardiac myopathy and left ventricular hypertrophy. ( n5, n9, n19-n21) Although Hoegerman et al.( n22) found no association between recreational cocaine use and let's ventricular mass in the Coronary Artery Risk Development in Young Adults study (CARDIA), an increased likelihood of atherosclerosis was reported in cocaine-related fatality cases compared with fatalities due to other causes.( n20, n23) have been cross-sectional and limited to case reports or clinical series. Many of the study samples have been, by necessity, small and potentially biased. Findings have been inconsistent across published reports; lifestyle and other risk factor data have not been included in case reports and clinical series.
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The CARDIA study aims to. identify the distribution of coronary heart disease risk factors (including illicit drug use) among a randomly sampled biethnic cohort of men and women of varied socioeconomic status, aged 20 to 32 in 1987. CARDIA also includes unique data on lifestyle and behavioral characteristics that may influence cocaine use. The longitudinal design, the cardiovascular focus of CARDIA, and the inclusion of essentially healthy individuals at baseline provide a unique opportunity to assess the cardiovascular consequences of chronic cocaine use. The purpose of this paper is twofold: ( 1) to assess the cross-sectional relationship of lifetime cocaine use and cardiovascular disease risk factors in 1987, and ( 2) to evaluate the relationship between lifetime cocaine use in 1987 and cardiovascular disease risk factors 5 years later.
Methods
From March 1985 through June 1986, 5115 Black and White men and women aged 18 to 30 were recruited and examined at one of four clinical sites: Birmingham, Ala; Chicago, Ill; Minneapolis, Minn; and Oakland, Calif. For the Birmingham, Chicago, and Minneapolis centers, participants were randomly recruited from the total community or from selected census tracts in the community. For the Oakland center, participants were randomly recruited from the Kaiser-Permanente Health Plan membership. Recruitment methods effectively achieved the study aim of a cohort approximately balanced on two levels of age (</=24 years, >24 years), race (Black and White), sex, and education (</= high school, > high school). Response rates averaged 53% of contacted eligible subjects. Details on sampling methods and clinic protocol have been published previously. ( n26-n28) This cohort was reexamined in 1987/88 (with a retention rate of 90.4%), again in 1990/91 (with a retention rate of 85.1%), and finally in 1992/93 (with a retention rate of 80.6%).
Study Sample
The 4624 subjects who attended the second CARDIA examination in 1987 are the focus of this report, given that cocaine data were not collected at the baseline examination in 1985. Subjects were excluded from all analyses if they did not attend the fourth examination in 1992 or if cocaine use data were missing at either examination. Cocaine use data were missing at the second examination for 52 participants. Between the second and fourth examinations 36 subjects died, and 662 participants did not attend the 1992 examination, yielding a 5-year retention rate of 84.7% (3874/4572). Cocaine use data at the fourth examination were missing for 26 participants. Thus, the final sample totaled 3848 participants. Sample sizes in some analyses were slightly smaller because of other occasional missing data.
Dependent Variables: Cardiovascular Parameters
Blood pressure and heart rate were measured in 1987 and 1992. After subjects had a 5-minute rest, trained technicians measured seated blood pressure three times at 1-minute intervals using a Hawksley random-zero sphygmomanometer according to a standard protocol. First-phase Korotkoff sounds were recorded as systolic blood pressure; fifth-phase Korotkoff sounds were recorded as diastolic blood pressure. The two final blood pressure measurements were averaged to reduce variability. Pulse was defined as beats per 30 seconds from the radial artery. At each examination, persons with systolic blood pressure values exceeding 140, diastolic blood pressure exceeding 90, or on blood pressure medications were considered hypertensive. each examination. Beginning in 1987, this questionnaire collected information about lifetime ever use of cocaine or crack, past month use of cocaine or crack, and lifetime frequency of cocaine use. In 1987, lifetime cocaine experience was evaluated with the use of a modification of the question from the National Household Survey on Drug Abuse.( n29) Lifetime frequency of use was reduced to five levels: none, 1 to 2 times, 3 to 10 times (compared with 3 to 5 times and 6 to 10 times in the national survey), 11 to 91 times (compared with 11 to 49 times and 50 to 99 times in the national survey), and at least 100 times (compared with 100 to 199 times and at least 200 times in the national survey).
Covariates
Sociodemographic characteristics. Educational attainment was defined as the years of formal schooling completed. Years of education were calculated as a semicontinuous variable ranging from 1 year to 20 or more years in 1987.
Substance use behavior. Data on licit and illicit substance use were collected in 1987. Consistent with previous studies of smoking and cardiovascular disease, tobacco smoking was dichotomized as smoking at least five cigarettes per week almost every week or smoking less than that amount.( n26-n28) Alcohol consumption was classified as the prevalence of past year drinking and the mean ethanol intake per day. Respondents were defined as past-year drinkers if they had consumed any alcoholic beverages within the past year. Ethanol intake was calculated using the formula developed by Dyer et al.( n30) : mean milligrams of ethanol per day = (number of 12 oz beers per week/7 days per week * 14.2 mL ethanol per beer) + (number of 5 oz glasses of wine per week/7 * 17.2 mL ethanol per wine) + (number of 1.5 oz hard liquor drinks per week/7 * 19.09 mL ethanol per drink). Current marijuana use was classified as at least 1 day of marijuana use in the past month. Because of the low prevalence of amphetamine and heroin use in this cohort, use of these two substances was grouped into one variable reflecting at least 1 day of other illicit drug use in the past month.
Physical activity. Physical activity in 1987 was measured via the Physical Activity History questionnaire, shown in previous research to be a valid, reliable indicator of physical activity.( n31) The Physical Activity History score includes the scores for moderate and vigorous activities; low-intensity activities contribute little additional information and therefore are not included.
Anthropometric measurements. Subjects were weighed using a balance scale; height was measured in stocking feet. Body mass index was computed by dividing weight in kilograms by height in square meters.
Waist measurements were taken laterally midway between the iliac crest and the rib cage and, anteriorly, midway between the xiphoid process of the sternum and the umbilicus. Hip girth was measured anteriorly at the symphysis pubis and posteriorly at the level of maximal protrusion of the gluteal muscles. The mean of two waist measures divided by the mean of two hip measures yielded the waist-hip ratio. Skinfold measurements were taken on the right side of the participant with a Harpenden skinfold caliper. The mean of two triceps measures and the mean of two suprailiac measures were added together to yield the skinfold measurement.
Data Analysis
Substance use behavior and cardiovascular characteristics were compared across categories of lifetime cocaine experience in 1987 with the use of analysis of variance (SAS PROC GLM) for continuous variables and chi-square (SAS PROC FREQ) for categorical variables.( n32) The cross-sectional and long-term relationships between cocaine experience in 1987 and cardiovascular parameters in 1987 and 1992, after adjustment for other cardiovascular disease risk factors, were evaluated with the use of linear regression (SAS PROC GLM) for continuous outcomes and logistic regression (SAS PROC LOGISTIC) for dichotomous outcomes. Models evaluating the long-term relationship between cocaine use and cardiovascular disease risk factors were also adjusted for the baseline level of the dependent variable. https://web.ebscohost.com/ehost/detail?vid=8&hid=12&sid=34078…gr102&bdata=JnNpdGU9ZWhvc3QtbGl2ZQ%3d%3d#db=byh&AN=9705292376
The interaction of sex, ethnicity, and cocaine use was evaluated to determine their cross-sectional and long-term multivariate relationship with the cardiovascular disease risk factors.
Results
No consistent evidence was found of any interaction between sex, ethnicity, and cocaine use and any of the outcome measures. Sex-specific analyses will be reported, however, because cocaine use behavior differed markedly by sex (but not ethnicity) in the CARDIA cohort.( n33) More extensive cocaine use experience was associated in both men and women with being White, older, and less educated (Table 1) . Higher levels of licit and illicit substance use behavior were reported by those reporting more extensive cocaine experience. A positive dose-response relationship was noted in smoking prevalence; cigarettes smoked per day; mean alcohol intake per day; and past month use of marijuana, cocaine, and other illicit drugs across cocaine experience categories.
In cross-sectional analysis, physical activity levels in 1987 increased with increased lifetime cocaine use experience in both men and women (Table 2 ). In men, a positive linear relationship was noted between waist-hip ratio and cocaine use while body mass index and sum of skinfold measurements were stable across cocaine use categories; in women, body mass index and sum of skinfold measurements decreased with increased lifetime cocaine use experience and waist-hip ratio was stable (Table 2) .
Systolic blood pressure, diastolic blood pressure, pulse pressure, heart rate, and hypertension prevalence in men were stable across lifetime cocaine experience categories in 1987. In women, however, systolic and diastolic blood pressure declined as lifetime cocaine use experience in 1987 increased, whereas pulse pressure and heart rate were stable across cocaine use categories (Table 2) .
Lifetime cocaine use experience in 1987, after adjustment for age, ethnicity, daily alcohol intake, cigarettes smoked per day, body mass index, sum of skinfolds, physical activity, and other illicit drug use, was not related to blood pressure, pulse pressure difference, heart rate, or hypertension prevalence in crosssectional analysis in either men or women (data not shown). The long-term, multivariate relationships between lifetime cocaine use experience in 1987 and blood pressure, pulse pressure difference, and heart rate in 1992 are shown in Table 3 . No relationship was evident between lifetime cocaine use experience and blood pressure in men or women. An isolated finding of decreased heart rate with increased cocaine use experience was noted in women, while an isolated finding of increased pulse pressure difference with increased cocaine use experience was evident in men. The odds of hypertension in 1992 were not related to 1987 lifetime cocaine use experience in either sex (Table 4) .
Discussion
This first prospective study of the association of extensive lifetime cocaine use with cardiovascular disease risk factors showed no relationship between the two in men or women in either crosssectional multivariate analysis in 1987 or in multivariate analysis from 1987 to 1992. Additionally, lifetime cocaine use experience was not related to the odds of hypertension in 1987 nor to incident hypertension from 1987 to 1992.
Previous studies have demonstrated the acute effects of cocaine and have implicated cocaine use in the clinical presentation of cardiovascular dysfunction and fatality. The long-term, chronic effects of cocaine use have not been demonstrated, and the relationship between cocaine-induced cardiovascular disease risk factors and cardiovascular events has not been studied. The results of our study suggest that lifetime cocaine use among Black and White men and women aged 20 to 32 years is not associated with higher blood pressure, higher heart rate, or increased prevalence of hypertension cross-sectionally in 1987 or 5 years later. As a result, cocaine-induced cardiovascular events or cardiac myopathy in this age group may not be strongly related to changes in cardiovascular disease risk factors; in fact, cocaine may be related to cardiovascular events only via its acute effects.
The results of this study must be interpreted in light of several design features: the subjects included, the https://web.ebscohost.com/ehost/detail?vid=8&hid=12&sid=34078…gr102&bdata=JnNpdGU9ZWhvc3QtbGl2ZQ%3d%3d#db=byh&AN=9705292376 reliance on self-reported data, the time period of the study, and the sensitivity of the cocaine use data. The CARDIA study is a longitudinal cohort study selected from four urban centers and balanced on two levels of age, ethnicity, sex, and educational attainment at baseline. Although it is a structured study sample and not generalizable to the United States as a whole, there is no reason to believe that the subjects included in the CARDIA study are different from other people in the sampling frame with similar selection characteristics. They are, however, more likely to be stable individuals since ( 1) no differential loss to follow-up was noted at the fourth examination across the second examination's cocaine use categories, ( 2) they were followed for 7 years, and ( 3) they were able to comprehend and comply with a 4-hour examination. Hence, they are not likely to have suffered the extreme effects of chronic, heavy drug use. As a result, the effects of lifetime cocaine use experience may be underestimated in this study.
The validity and reliability of self-reported substance use has been questioned. Self-reported illicit drug data have been viewed as underrepresenting the prevalence of drug use owing to hesitancy in admitting illegal, socially unacceptable behaviors and to poor recall of sporadic drug use. ( n34, n35) To combat this, several features of the CARDIA study design help minimize underreporting of illicit drug use: CARDIA employs a self-administered questionnaire rather than a face-to-face or telephone interview to assess substance use( n36); illicit drug use is not the main focus of the examination but one small component of a comprehensive cardiovascular examination; and the examination site is an isolated clinic not associated with any law enforcement agency, governmental agency, employer, or medical care facility. Additionally, confidentiality is assured at each examination. Although cocaine use data were not collected until the second examination, the prevalence of marijuana use was high at the first examination and participants had not experienced adverse effects of self-reporting illicit drug data. Discrepant reports of cocaine use from 1987 to 1992 were given by only 8.0% of the sample and were primarily the result of ever users in 1987 reporting never use in 1992 (7.1%). Among ever users or current users in 1987 who reported never use in 1992, 82.9% also reported 10 or fewer lifetime experiences with cocaine in 1987, suggesting that discrepant reporting is the result of inaccurate recall of low usage. Nevertheless, findings in this study may be attenuated because of an underreporting of cocaine use.
Finally, the measure of cocaine use experience assesses the lifetime frequency of cocaine use prior to the 1987 examination; however, the intensity of use in the previous year and the intensity of use from 1987 to 1992 are unknown. Since previous studies suggest that the effects of cocaine are reversible in the absence of cocaine use, a more specific categorization of extensive cocaine use incorporating the intensity of use, particularly in the recent past, may yield different results in this age group.
Cocaine-related cardiovascular events have rarely been reported in adults older than 40 years of age.( n6-n19) If, in fact, cocaine-related cardiovascular events are mediated by risk factor changes resulting from exposure to cocaine, such changes would likely be evident in younger adults. It may be that the 5-year evaluation period is insufficient to detect important cocaine-related changes in these cardiovascular disease risk factors. Further studies are thus needed to determine whether continued exposure is associated with cardiovascular disease risk factors in later life. Legend for Table: a -(n = 986) b -(n = 167) c -(n = 271) https://web.ebscohost.com/ehost/detail?vid=8&hid=12&sid=34078…gr102&bdata=JnNpdGU9ZWhvc3QtbGl2ZQ%3d%3d#db=byh&AN=9705292376 Legend for Table: a -(n = 986) [a] Unit of heavy and moderate activity/year; range = 0 to 2126 units.
[b] Subscapular and triceps.
[c] Range = 0 to 2126 units. Linear slope -0.14 P trend .38
[a] Adjusted for age, ethnicity, amount of alcohol per day, number of cigarettes per day, physical activity, waist-hip ratio, sum of skinfolds, body mass index, marijuana use, other illicit drug use, and baseline hypertension.
